Monitoring Patients Receiving Lopressor IV Push

Continuously monitor vital signs, including heart rate, blood pressure, and respiratory rate, for at least one hour post-administration. Pay close attention to any significant changes.

Observe the patient for signs of hypotension, bradycardia, or other adverse effects. Report any abnormalities immediately to the physician.

ECG monitoring is recommended, especially in patients with pre-existing cardiac conditions. Look for any rhythm disturbances or changes in ST segment.

Assess the patient’s mental status and level of consciousness. Report any confusion, dizziness, or syncope.

Maintain intravenous access and be prepared to administer appropriate supportive measures, such as fluids or atropine, if necessary.

Document all vital signs, observations, and interventions meticulously in the patient’s medical record. Include any medication adjustments made in response to observed changes.

Educate the patient and family about potential side effects and the importance of reporting any concerns. Provide clear instructions regarding post-discharge care.